A single high dose of radiotherapy is as effective in relieving the pain from vertebral bone metastases as ten smaller treatments according to new research from the Radiation Therapy Oncology Group (RTOG) presented at the American Society of Clinical Oncology Annual Meeting in Orlando.
Cosmetic outcome and Radiation Therapy Oncology Group (RTOG)/European Organization for Research and Treatment of Cancer (EORTC) late radiation morbidity were also equivalent.
Study participants were enrolled in two Radiation Therapy Oncology Group clinical trials and completed a baseline quality-of-life questionnaire that included an emotional well-being subscale.
A clinical trial by Fisher et al, (20) which prospectively assessed skin toxicity over the course of breast irradiation using Radiation Therapy Oncology Group (RTOG) toxicity criteria, found less than 3% of patients developed grade III toxicity.
Our results certainly support the 0 mm GTV-CTV margin being used by the on-going Radiation Therapy Oncology Group 9311 study using 3-dimensional conformal radiation therapy for non-small cell lung cancer.
[9,10] The Radiation Therapy Oncology Group recently reported the findings of its prospective, randomized, 2-year comparison of once-daily fractionation, hyperfractionation, and two variants of accelerated fractionation.
Survival Results Better Than Any Previously Reported by RTOG CHICAGO -- Radiation Therapy Oncology Group (RTOG) investigators and ImClone Systems Incorporated (Nasdaq: IMCL) today announced that adding the biologic agent cetuximab (ERBITUX([R])) to chemotherapy and radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) resulted in higher median survival rates and two-year overall survival rates than previous RTOG studies in patients with Stage III A/B inoperable NSCLC.
The largest and most definitive study to date has found that patients with stage III or IV oropharyngeal cancer (cancers of the upper throat) whose tumors contained the human papillomavirus (HPV) have better outcomes than patients with HPV-negative disease according to new research from the Radiation Therapy Oncology Group (RTOG).
